The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global PD-1 Antibody Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global PD-1 Antibody Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1774878

No of Pages : 117

Ask Your Query

Synopsis
The global PD-1 Antibody Drug market size was valued at USD 33960 million in 2022 and is forecast to a readjusted size of USD 83340 million by 2029 with a CAGR of 13.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

PD-1 is an immune checkpoint inhibitor, which is relatively widely used clinically

This report is a detailed and comprehensive analysis for global PD-1 Antibody Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global PD-1 Antibody Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global PD-1 Antibody Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global PD-1 Antibody Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
  • Global PD-1 Antibody Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for PD-1 Antibody Drug
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace.

This report profiles key players in the global PD-1 Antibody Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Thermo Fisher, InvivoGen, BioVision Inc. and Abcam, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

PD-1 Antibody Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Pembrolizumab
  • Nivolumab
  • Sindilimab
  • Toripalimab
  • Other

Market segment by Application

  • Hospital
  • Clinic
  • Other

Major players covered

  • Novartis
  • Thermo Fisher
  • InvivoGen
  • BioVision Inc.
  • Abcam
  • Bristol-Myers Squibb
  • Merck
  • Ono Pharmaceutical Co., Ltd
  • Eli Lilly
  • Chugai Pharmaceutical Co., Ltd
  • BeiGene
  • AbbVie
  • TG Therapeutics, Inc
  • Beijing Yiqiao Shenzhou Technology Co., Ltd.
  • 3SBio

Market segment by region, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe PD-1 Antibody Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PD-1 Antibody Drug, with price, sales, revenue and global market share of PD-1 Antibody Drug from 2018 to 2023.
Chapter 3, the PD-1 Antibody Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PD-1 Antibody Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and PD-1 Antibody Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of PD-1 Antibody Drug.
Chapter 14 and 15, to describe PD-1 Antibody Drug sales channel, distributors, customers, research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of PD-1 Antibody Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global PD-1 Antibody Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Pembrolizumab
1.3.3 Nivolumab
1.3.4 Sindilimab
1.3.5 Toripalimab
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global PD-1 Antibody Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global PD-1 Antibody Drug Market Size & Forecast
1.5.1 Global PD-1 Antibody Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global PD-1 Antibody Drug Sales Quantity (2018-2029)
1.5.3 Global PD-1 Antibody Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis PD-1 Antibody Drug Product and Services
2.1.4 Novartis PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Thermo Fisher
2.2.1 Thermo Fisher Details
2.2.2 Thermo Fisher Major Business
2.2.3 Thermo Fisher PD-1 Antibody Drug Product and Services
2.2.4 Thermo Fisher PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Thermo Fisher Recent Developments/Updates
2.3 InvivoGen
2.3.1 InvivoGen Details
2.3.2 InvivoGen Major Business
2.3.3 InvivoGen PD-1 Antibody Drug Product and Services
2.3.4 InvivoGen PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 InvivoGen Recent Developments/Updates
2.4 BioVision Inc.
2.4.1 BioVision Inc. Details
2.4.2 BioVision Inc. Major Business
2.4.3 BioVision Inc. PD-1 Antibody Drug Product and Services
2.4.4 BioVision Inc. PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 BioVision Inc. Recent Developments/Updates
2.5 Abcam
2.5.1 Abcam Details
2.5.2 Abcam Major Business
2.5.3 Abcam PD-1 Antibody Drug Product and Services
2.5.4 Abcam PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Abcam Recent Developments/Updates
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb PD-1 Antibody Drug Product and Services
2.6.4 Bristol-Myers Squibb PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol-Myers Squibb Recent Developments/Updates
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck PD-1 Antibody Drug Product and Services
2.7.4 Merck PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Recent Developments/Updates
2.8 Ono Pharmaceutical Co., Ltd
2.8.1 Ono Pharmaceutical Co., Ltd Details
2.8.2 Ono Pharmaceutical Co., Ltd Major Business
2.8.3 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
2.8.4 Ono Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly PD-1 Antibody Drug Product and Services
2.9.4 Eli Lilly PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Eli Lilly Recent Developments/Updates
2.10 Chugai Pharmaceutical Co., Ltd
2.10.1 Chugai Pharmaceutical Co., Ltd Details
2.10.2 Chugai Pharmaceutical Co., Ltd Major Business
2.10.3 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Product and Services
2.10.4 Chugai Pharmaceutical Co., Ltd PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
2.11 BeiGene
2.11.1 BeiGene Details
2.11.2 BeiGene Major Business
2.11.3 BeiGene PD-1 Antibody Drug Product and Services
2.11.4 BeiGene PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BeiGene Recent Developments/Updates
2.12 AbbVie
2.12.1 AbbVie Details
2.12.2 AbbVie Major Business
2.12.3 AbbVie PD-1 Antibody Drug Product and Services
2.12.4 AbbVie PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 AbbVie Recent Developments/Updates
2.13 TG Therapeutics, Inc
2.13.1 TG Therapeutics, Inc Details
2.13.2 TG Therapeutics, Inc Major Business
2.13.3 TG Therapeutics, Inc PD-1 Antibody Drug Product and Services
2.13.4 TG Therapeutics, Inc PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 TG Therapeutics, Inc Recent Developments/Updates
2.14 Beijing Yiqiao Shenzhou Technology Co., Ltd.
2.14.1 Beijing Yiqiao Shenzhou Technology Co., Ltd. Details
2.14.2 Beijing Yiqiao Shenzhou Technology Co., Ltd. Major Business
2.14.3 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Product and Services
2.14.4 Beijing Yiqiao Shenzhou Technology Co., Ltd. PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Beijing Yiqiao Shenzhou Technology Co., Ltd. Recent Developments/Updates
2.15 3SBio
2.15.1 3SBio Details
2.15.2 3SBio Major Business
2.15.3 3SBio PD-1 Antibody Drug Product and Services
2.15.4 3SBio PD-1 Antibody Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 3SBio Recent Developments/Updates
3 Competitive Environment: PD-1 Antibody Drug by Manufacturer
3.1 Global PD-1 Antibody Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global PD-1 Antibody Drug Revenue by Manufacturer (2018-2023)
3.3 Global PD-1 Antibody Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of PD-1 Antibody Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 PD-1 Antibody Drug Manufacturer Market Share in 2022
3.4.2 Top 6 PD-1 Antibody Drug Manufacturer Market Share in 2022
3.5 PD-1 Antibody Drug Market: Overall Company Footprint Analysis
3.5.1 PD-1 Antibody Drug Market: Region Footprint
3.5.2 PD-1 Antibody Drug Market: Company Product Type Footprint
3.5.3 PD-1 Antibody Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global PD-1 Antibody Drug Market Size by Region
4.1.1 Global PD-1 Antibody Drug Sales Quantity by Region (2018-2029)
4.1.2 Global PD-1 Antibody Drug Consumption Value by Region (2018-2029)
4.1.3 Global PD-1 Antibody Drug Average Price by Region (2018-2029)
4.2 North America PD-1 Antibody Drug Consumption Value (2018-2029)
4.3 Europe PD-1 Antibody Drug Consumption Value (2018-2029)
4.4 Asia-Pacific PD-1 Antibody Drug Consumption Value (2018-2029)
4.5 South America PD-1 Antibody Drug Consumption Value (2018-2029)
4.6 Middle East and Africa PD-1 Antibody Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
5.2 Global PD-1 Antibody Drug Consumption Value by Type (2018-2029)
5.3 Global PD-1 Antibody Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
6.2 Global PD-1 Antibody Drug Consumption Value by Application (2018-2029)
6.3 Global PD-1 Antibody Drug Average Price by Application (2018-2029)
7 North America
7.1 North America PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
7.2 North America PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
7.3 North America PD-1 Antibody Drug Market Size by Country
7.3.1 North America PD-1 Antibody Drug Sales Quantity by Country (2018-2029)
7.3.2 North America PD-1 Antibody Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
8.2 Europe PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
8.3 Europe PD-1 Antibody Drug Market Size by Country
8.3.1 Europe PD-1 Antibody Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe PD-1 Antibody Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific PD-1 Antibody Drug Market Size by Region
9.3.1 Asia-Pacific PD-1 Antibody Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific PD-1 Antibody Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
10.2 South America PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
10.3 South America PD-1 Antibody Drug Market Size by Country
10.3.1 South America PD-1 Antibody Drug Sales Quantity by Country (2018-2029)
10.3.2 South America PD-1 Antibody Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa PD-1 Antibody Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa PD-1 Antibody Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa PD-1 Antibody Drug Market Size by Country
11.3.1 Middle East & Africa PD-1 Antibody Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa PD-1 Antibody Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 PD-1 Antibody Drug Market Drivers
12.2 PD-1 Antibody Drug Market Restraints
12.3 PD-1 Antibody Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of PD-1 Antibody Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of PD-1 Antibody Drug
13.3 PD-1 Antibody Drug Production Process
13.4 PD-1 Antibody Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 PD-1 Antibody Drug Typical Distributors
14.3 PD-1 Antibody Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock